Advertisement
Home Blog Page 3495
For patients with chronic back pain

Spondyloarthritis Features Can Identify Axial Spondyloarthritis

0
Presence of one of three features is good way to identify patients with axial spondyloarthritis
The incidence of primary chronic immune thrombocytopenia (cITP) is 2.30/100

Infection Risk Up Before Chronic Immune Thrombocytopenia

0
Increased risk of infections requiring inpatient, outpatient care within five years before cITP dx
Flexible

Flexible Duty-Hour Policies Don’t Harm Patient Outcomes

0
Residents assigned to flexible duty-hour group do not report dissatisfaction with education, well-being
For adults with symptomatic chronic sinusitis and nasal polyposis refractory to intranasal corticosteroids

Subcutaneous Dupilumab Reduces Nasal Polyp Burden

0
Greater reduction for addition of dupilumab to mometasone furoate nasal spray in chronic sinusitis
Seafood consumption is associated with increased brain levels of mercury

Mercury From Seafood Not Tied to Brain Neuropathology

0
Significant link for seafood consumption with less Alzheimer's disease pathology in APOE ε4 carriers
Tips for increasing patient adherence to treatment plans include patient engagement and addressing barriers to adherence

Tips Presented for Encouraging Treatment Adherence

0
Broad approach recommended, which includes patient engagement and addressing barriers
A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes

Protein Preload Boosts Vildagliptin’s Effects in Diabetes

0
Small whey preload augments plasma intact GLP-1 levels, slows gastric emptying
For people 60 and older

Researchers Say JNC8 Recs May Put Some Patients at Risk

0
Team says the treatment threshold is too high for those over 60 years of age
Iodixanol is associated with lower risk for contrast-induced nephropathy versus low-osmolar contrast media (LOCM); and among those receiving LOCM

Lower Risk of Contrast-Induced Nephropathy With Iodixanol

0
Greatest reduction for N-acetylcysteine in patients receiving low-osmolar contrast media
Two HIV-1 vaccines

Novel Vaccine Platform Shows Promise for HIV-1

0
HIV-1 vaccines with adenovirus and HIV-1 envelope A insert are well-tolerated, elicit immune responses